| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.26 | 0.4 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |